Compass Therapeutics (NASDAQ:CMPX – Get Free Report) had its price objective upped by equities researchers at HC Wainwright from $10.00 to $24.00 in a research report issued on Friday,Benzinga reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback